104 related articles for article (PubMed ID: 3081996)
21. Thromboxane synthesis in megakaryocytes isolated by centrifugal elutriation.
Worthington RE; Nakeff A
Blood; 1981 Jul; 58(1):175-8. PubMed ID: 6786393
[TBL] [Abstract][Full Text] [Related]
22. Megakaryocyte interaction with subendothelial extracellular matrix is associated with adhesion, platelet-like shape change, and thromboxane A2 production.
Levine RF; Eldor A; HyAm E; Gamliel H; Fuks Z; Vlodavsky I
Blood; 1985 Sep; 66(3):570-6. PubMed ID: 4027379
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of platelet prostaglandin synthetase by oral aspirin.
Burch JW; Stanford N; Majerus PW
J Clin Invest; 1978 Feb; 61(2):314-9. PubMed ID: 413839
[TBL] [Abstract][Full Text] [Related]
24. The effects of aspirin on megakaryocyte prostaglandin production.
Demers LM; Budin RE; Shaikh BS
Proc Soc Exp Biol Med; 1980 Jan; 163(1):24-9. PubMed ID: 6766214
[No Abstract] [Full Text] [Related]
25. Low-dose enteric-coated aspirin: a practical approach to continuous-release low-dose aspirin and presystemic acetylation of human platelet cyclooxygenase.
Jakubowski JA; Stampfer MJ; Vaillancourt R; Faigel D; Deykin D
J Lab Clin Med; 1986 Dec; 108(6):616-21. PubMed ID: 3097223
[TBL] [Abstract][Full Text] [Related]
26. Recovery of cyclooxygenase activity after aspirin in populations of platelets separated on stractan density gradients.
McDonald JW; Ali M
Prostaglandins Leukot Med; 1983 Nov; 12(3):245-52. PubMed ID: 6419234
[TBL] [Abstract][Full Text] [Related]
27. Heterogeneity in platelet cyclooxygenase inhibition by aspirin in coronary artery disease.
Lordkipanidzé M; Pharand C; Schampaert E; Palisaitis DA; Diodati JG
Int J Cardiol; 2011 Jul; 150(1):39-44. PubMed ID: 20207433
[TBL] [Abstract][Full Text] [Related]
28. Clinical pharmacology of cyclooxygenase inhibition and pharmacodynamic interaction with aspirin by floctafenine in Thai healthy subjects.
Maenthaisong R; Tacconelli S; Sritara P; Del Boccio P; Di Francesco L; Sacchetta P; Archararit N; Aryurachai K; Patrignani P; Suthisisang C
Int J Immunopathol Pharmacol; 2013; 26(2):403-17. PubMed ID: 23755755
[TBL] [Abstract][Full Text] [Related]
29. Low-dose aspirin in patients recovering from myocardial infarction. Evidence for a selective inhibition of thromboxane-related platelet function.
De Caterina R; Giannessi D; Bernini W; Gazzetti P; Michelassi C; L'Abbate A; Donato L; Patrignani P; Filabozzi P; Patrono C
Eur Heart J; 1985 May; 6(5):409-17. PubMed ID: 3930246
[TBL] [Abstract][Full Text] [Related]
30. Aspirin extrusion from human platelets through multidrug resistance protein-4-mediated transport: evidence of a reduced drug action in patients after coronary artery bypass grafting.
Mattiello T; Guerriero R; Lotti LV; Trifirò E; Felli MP; Barbarulo A; Pucci B; Gazzaniga P; Gaudio C; Frati L; Pulcinelli FM
J Am Coll Cardiol; 2011 Aug; 58(7):752-61. PubMed ID: 21816313
[TBL] [Abstract][Full Text] [Related]
31. Gallic acid, a dietary polyphenolic component, blunts the inhibition of platelet COX-1 by aspirin: preliminary in-vitro findings.
Crescente M; Cerletti C; de Gaetano G
Thromb Haemost; 2007 Jun; 97(6):1054-6. PubMed ID: 17549313
[No Abstract] [Full Text] [Related]
32. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
[TBL] [Abstract][Full Text] [Related]
33. Low-dose aspirin in pregnancy.
Sibai BM; Mirro R; Chesney CM; Leffler C
Obstet Gynecol; 1989 Oct; 74(4):551-7. PubMed ID: 2797631
[TBL] [Abstract][Full Text] [Related]
34. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
[TBL] [Abstract][Full Text] [Related]
35. Low-dose aspirin inhibits platelet and venous cyclo-oxygenase in man.
Preston FE; Greaves M; Jackson CA; Stoddard CJ
Thromb Res; 1982 Aug; 27(4):477-84. PubMed ID: 6815823
[TBL] [Abstract][Full Text] [Related]
36. The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes.
Rocca B; Santilli F; Pitocco D; Mucci L; Petrucci G; Vitacolonna E; Lattanzio S; Mattoscio D; Zaccardi F; Liani R; Vazzana N; Del Ponte A; Ferrante E; Martini F; Cardillo C; Morosetti R; Mirabella M; Ghirlanda G; Davì G; Patrono C
J Thromb Haemost; 2012 Jul; 10(7):1220-30. PubMed ID: 22471290
[TBL] [Abstract][Full Text] [Related]
37. Selective inhibition of platelet cyclooxygenase with controlled release, low-dose aspirin.
Vial JH; McLeod LJ; Roberts MS; Seville PR
Aust N Z J Med; 1990 Oct; 20(5):652-6. PubMed ID: 2126726
[TBL] [Abstract][Full Text] [Related]
38. Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.
Hanson SR; Harker LA; Bjornsson TD
J Clin Invest; 1985 May; 75(5):1591-9. PubMed ID: 3923041
[TBL] [Abstract][Full Text] [Related]
39. Differential inhibition of platelet thromboxane and lung prostacyclin production by sulphinpyrazone, acetylsalicylic acid and indomethacin by human tissues in vitro.
Toivanen J; Ylikorkala O; Viinikka L
Thromb Res; 1985 Feb; 37(4):493-502. PubMed ID: 3920778
[TBL] [Abstract][Full Text] [Related]
40. Low dose aspirin treatment in late pregnancy differentially inhibits cyclo-oxygenase in maternal platelets.
Ritter JM; Farquhar C; Rodin A; Thom MH
Prostaglandins; 1987 Nov; 34(5):717-22. PubMed ID: 3124218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
